Preliminary Results From A Phase 2 Trial Of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, And Prednisone (Chep-Bv) Followed By Bv Consolidation In Patients With Cd30-Positive Peripheral T-Cell Lymphomas
BLOOD（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要